ORIC Pharmaceuticals, Inc. (ORIC) — Dilution Risk Analysis

Current Snapshot

ORIC Pharmaceuticals, Inc. (ORIC) has a DilutionWatch score of 32/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
103,652,656 Source
Public Float
82,527,306 Source
Float as % of Outstanding
79.6%

Dilution Risk Score

Score: 32/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

1 shelf registration or ATM offering filing detected in recent history.

Recent filing forms in the source payload: 8-K 2, XBRL 2, 4 1, 424B5 1.

FormFiledAccession
8-K 2026-07-30 0001193125-26-326309
xbrl 2026-06-30 xbrl-3231-xbrl_warrant
4 2026-02-26 0001695028-26-000004
424B5 2026-02-23 0001193125-26-064275
8-K 2026-02-23 0001193125-26-064291
xbrl 2020-12-31 xbrl-3231-xbrl_convertible

Dilution Risk Drivers

DriverStored ValueSource
ATM offering capacity remaining $60,000,000 Source
Cash runway 13 months Source
Three-year share count growth 90.01% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 32/10) Source
Cash Runway
13 months Source
ATM Offering Capacity Remaining
$60,000,000 Source
Share Count Growth (3-Year)
90.01% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.